Related references
Note: Only part of the references are listed.Hypoxia-inducible factor 1 (HIF-1) is a new therapeutic target in JAK2V617F-positive myeloproliferative neoplasms
Julian Baumeister et al.
LEUKEMIA (2020)
Leukemia secondary to myeloproliferative neoplasms
Andrew J. Dunbar et al.
BLOOD (2020)
3-[(1S,2S,3R)-2,3-Difluoro-1-hydroxy-7-methylsulfonylindan-4-yl]oxy-5-fluorobenzonitrile (PT2977), a Hypoxia-Inducible Factor 2α (HIF-2α) Inhibitor for the Treatment of Clear Cell Renal Cell Carcinoma
Rui Xu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Blast phase myeloproliferative neoplasm: Mayo-AGIMM study of 410 patients from two separate cohorts
Ayalew Tefferi et al.
LEUKEMIA (2018)
Pathobiological Pseudohypoxia as a Putative Mechanism Underlying Myelodysplastic Syndromes
Yoshihiro Hayashi et al.
CANCER DISCOVERY (2018)
JARID2 Functions as a Tumor Suppressor in Myeloid Neoplasms by Repressing Self-Renewal in Hematopoietic Progenitor Cells
Hamza Celik et al.
CANCER CELL (2018)
PinAPL-Py: A comprehensive web-application for the analysis of CRISPR/Cas9 screens
Philipp N. Spahn et al.
SCIENTIFIC REPORTS (2017)
On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models
Hyejin Cho et al.
NATURE (2016)
Energy sensing and cancer: LKB1 function and lessons learnt from Peutz-Jeghers syndrome
Boris Y. Shorning et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2016)
The Mitochondrial Respiratory Chain Is Required for Organismal Adaptation to Hypoxia
Robert B. Hamanaka et al.
CELL REPORTS (2016)
Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9
Michael C. Gundry et al.
CELL REPORTS (2016)
LKB1 Inactivation Elicits a Redox Imbalance to Modulate Non-small Cell Lung Cancer Plasticity and Therapeutic Response
Fuming Li et al.
CANCER CELL (2015)
Suppressors of superoxide production from mitochondrial complex III
Dam L. Orr et al.
NATURE CHEMICAL BIOLOGY (2015)
Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors
S. Cerquozzi et al.
BLOOD CANCER JOURNAL (2015)
Convergence of Hypoxia and TGFβ Pathways on Cell Cycle Regulation in Human Hematopoietic Stem/Progenitor Cells
Albertus T. J. Wierenga et al.
PLOS ONE (2014)
Genomic and functional analysis of leukemic transformation of myeloproliferative neoplasms
Raajit Rampal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Loss of the tumor suppressor LKB1 promotes metabolic reprogramming of cancer cells via HIF-1α
Brandon Faubert et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study
A. Tefferi et al.
LEUKEMIA (2013)
Acute Myeloid Leukemia Following a Myeloproliferative Neoplasm: Clinical Characteristics, Genetic Features and Effects of Therapy
Mark L. Heaney et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2013)
Regulation of the HIF-1α Level Is Essential for Hematopoietic Stem Cells
Keiyo Takubo et al.
CELL STEM CELL (2010)
Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells
Daisuke Nakada et al.
NATURE (2010)
The Lkb1 metabolic sensor maintains haematopoietic stem cell survival
Sushma Gurumurthy et al.
NATURE (2010)
Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem cells
Boyi Gan et al.
NATURE (2010)
mTOR and HIF-1α-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome
David B. Shackelford et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The natural history and treatment outcome of blast phase BCR-ABL(-) myeloproliferative neoplasms
Constantine S. Tam et al.
BLOOD (2008)
Mitochondrial complex III regulates hypoxic activation of HIF
T. Klimova et al.
CELL DEATH AND DIFFERENTIATION (2008)
Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation
JK Brunelle et al.
CELL METABOLISM (2005)
Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein
K Kondo et al.
CANCER CELL (2002)
Establishment and characterization of a new human megakaryoblastic cell line (SET-2) that spontaneously matures to megakaryocytes and produces platelet-like particles
K Uozumi et al.
LEUKEMIA (2000)
Share Paper
